← Back to Search

Restorative Eye Treatment (RET) cream for Droopy Eyelid

N/A
Waitlist Available
Led By Wendy W Lee, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants willing to avoid extended periods of sun exposure and all use of tanning beds for the duration of the study.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 month prior to blepharoplasty surgery
Awards & highlights

Study Summary

This trial will test if a new eye treatment can help improve skin quality and reduce scarring before and after surgery.

Eligible Conditions
  • Droopy Eyelids
  • Droopy Eyelid

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You agree to avoid prolonged exposure to sunlight and tanning beds during the study.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 month prior to blepharoplasty surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 month prior to blepharoplasty surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Collagen Content
Elastin Content
Post operative bruising
Secondary outcome measures
Post operative swelling

Trial Design

2Treatment groups
Experimental Treatment
Group I: RET Untreated eye Plus INhance GroupExperimental Treatment1 Intervention
Participants randomized to not receive the RET intervention will not receive any intervention prior to scheduled standard of care (SOC) blepharoplasty. After surgery, participants will receive INhance with Trihex technology applied to both eyelids daily for 10 consecutive days post surgery.
Group II: RET Treated Eye Plus INhance GroupExperimental Treatment2 Interventions
Participants randomized to receive the restorative eye treatment (RET) intervention on either the left or right eyelid will administer the RET cream on the eyelid daily for 4 consecutive weeks prior to scheduled standard of care (SOC) blepharoplasty. After surgery, participants will receive INhance with Trihex technology applied to both eyelids daily for 10 consecutive days post surgery.

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
899 Previous Clinical Trials
409,719 Total Patients Enrolled
Wendy W Lee, MDPrincipal InvestigatorUniversity of Miami
2 Previous Clinical Trials
21 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment currently open for this study?

"Contrary to what is stated on clinicaltrials.gov, this medical trial is not currently recruiting individuals. Originally posted in May 1st 2020 and last updated in the 16th of that same month, there are presently 13 other trials which are actively seeking patients."

Answered by AI
~3 spots leftby Apr 2025